Korean practice guidelines for gastric cancer 2022: An evidence-based, multidisciplinary approach

The Development Working Group for the Korean Practice Guidelines for Gastric Cancer 2022 Task Force Team

Research output: Contribution to journalArticlepeer-review

47 Scopus citations


Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this is the 4th gastric cancer guideline published in Korea which is the revised version of previous evidence-based approach in 2018. Current guideline is a collaborative work of the interdisciplinary working group including experts in the field of gastric surgery, gastroenterology, endoscopy, medical oncology, abdominal radiology, pathology, nuclear medicine, radiation oncology and guideline development methodology. Total of 33 key questions were updated or proposed after a collaborative review by the working group and 40 statements were developed according to the systematic review using the MEDLINE, Embase, Cochrane Library and KoreaMed database. The level of evidence and the grading of recommendations were categorized according to the Grading of Recommendations, Assessment, Development and Evaluation proposition. Evidence level, benefit, harm, and clinical applicability was considered as the significant factors for recommendation. The working group reviewed recommendations and discussed for consensus. In the earlier part, general consideration discusses screening, diagnosis and staging of endoscopy, pathology, radiology, and nuclear medicine. Flowchart is depicted with statements which is supported by meta-analysis and references. Since clinical trial and systematic review was not suitable for postoperative oncologic and nutritional follow-up, working group agreed to conduct a nationwide survey investigating the clinical practice of all tertiary or general hospitals in Korea. The purpose of this survey was to provide baseline information on follow up. Herein we present a multidisciplinary-evidence based gastric cancer guideline.

Original languageEnglish
Pages (from-to)3-106
Number of pages104
JournalJournal of Gastric Cancer
Issue number1
StatePublished - Jan 2023

Bibliographical note

Funding Information:
Seong-Ho Kong has received research funding from Stryker Co., Ltd. and Medtronic Inc. as the principal investigator and is the CEO of VITCAL, Co., Ltd. No potential conflict of interest relevant to this article was reported.

Funding Information:
This work was supported by The Korean Gastric Cancer Association and The Korean Cancer Management Guideline Network (KCGN), a research project supported by the Korean Ministry of Health and Welfare, 2021 commissioned task to the National Cancer Center (Grant number; NCC-2112570-1, NCC-2112570-2, NCC-2112570-3).

Publisher Copyright:
© 2023. Korean Gastric Cancer Association


  • Chemotherapy
  • Endoscopy
  • Guidelines
  • Stomach neoplasms
  • Surgery


Dive into the research topics of 'Korean practice guidelines for gastric cancer 2022: An evidence-based, multidisciplinary approach'. Together they form a unique fingerprint.

Cite this